Treatment of triple negative breast cancer and impact on patient survival

Detalhes bibliográficos
Autor(a) principal: Victória Mota Lima, Ana
Data de Publicação: 2022
Outros Autores: Pinheiro de Lima, Wenderson
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://onco.news/index.php/journal/article/view/54
Resumo: Describe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor.
id RCAP_c71b4a5a373068b4dc6123168c4d7e5e
oai_identifier_str oai:oai.onco.news:article/54
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Treatment of triple negative breast cancer and impact on patient survivalTratamento do câncer de mama triplo negativo e impacto na sobrevida das pacientesNeoplasia triplo-negativaAntineoplásicosImunohistoquímicaTriple-negative neoplasiaAntineoplasticsImmunohistochemistryDescribe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor.Descrever as opções terapêuticas disponíveis e analisar a expectativa de vida de mulheres diagnosticadas com câncer de mama triplo-negativo. Tratou-se de uma revisão sistemática de literatura, foram utilizadas as plataformas de pesquisa LILACS, BVS, PubMed e Periódicos capes para encontrar artigos publicados de 2015 à 2021 nos idiomas português, inglês e espanhol. Foram aplicadas as palavras-chave “câncer de mama triplo negativo” e “expectativa de vida”, utilizando o operador booleano E (AND). Ao final foram selecionados 14 estudos que se adequavam nos critérios de inclusão. O câncer de mama triplo-negativo apresenta limitadas opções terapêuticas devido sua classificação imuno-histoquímica, sendo assim submetido constantemente a quimioterapia, radioterapia e procedimento cirúrgico que deixam a paciente fragilizada. Entretanto, outras metodologias como a imunoterapia e uso de fármacos com diferentes alvos terapêuticos estão em desenvolvimento, resultados preliminares demonstram um aumento na sobrevida das pacientes e possibilidade de um futuro promissor na terapia do tumor triplo negativo.AEOP – Associação de Enfermagem Oncológica Portuguesa2022-11-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/54Onco.news; No. 45 (2022): Onco.News Journal (july-december); e054Onco.News; N.º 45 (2022): Revista Onco.News (julho-dezembro); e0542183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/54https://onco.news/index.php/journal/article/view/54/108Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Limainfo:eu-repo/semantics/openAccessVictória Mota Lima, AnaPinheiro de Lima, Wenderson2024-03-16T07:55:13Zoai:oai.onco.news:article/54Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:20.227203Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Treatment of triple negative breast cancer and impact on patient survival
Tratamento do câncer de mama triplo negativo e impacto na sobrevida das pacientes
title Treatment of triple negative breast cancer and impact on patient survival
spellingShingle Treatment of triple negative breast cancer and impact on patient survival
Victória Mota Lima, Ana
Neoplasia triplo-negativa
Antineoplásicos
Imunohistoquímica
Triple-negative neoplasia
Antineoplastics
Immunohistochemistry
title_short Treatment of triple negative breast cancer and impact on patient survival
title_full Treatment of triple negative breast cancer and impact on patient survival
title_fullStr Treatment of triple negative breast cancer and impact on patient survival
title_full_unstemmed Treatment of triple negative breast cancer and impact on patient survival
title_sort Treatment of triple negative breast cancer and impact on patient survival
author Victória Mota Lima, Ana
author_facet Victória Mota Lima, Ana
Pinheiro de Lima, Wenderson
author_role author
author2 Pinheiro de Lima, Wenderson
author2_role author
dc.contributor.author.fl_str_mv Victória Mota Lima, Ana
Pinheiro de Lima, Wenderson
dc.subject.por.fl_str_mv Neoplasia triplo-negativa
Antineoplásicos
Imunohistoquímica
Triple-negative neoplasia
Antineoplastics
Immunohistochemistry
topic Neoplasia triplo-negativa
Antineoplásicos
Imunohistoquímica
Triple-negative neoplasia
Antineoplastics
Immunohistochemistry
description Describe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-09
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://onco.news/index.php/journal/article/view/54
url https://onco.news/index.php/journal/article/view/54
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/54
https://onco.news/index.php/journal/article/view/54/108
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Lima
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Lima
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 45 (2022): Onco.News Journal (july-december); e054
Onco.News; N.º 45 (2022): Revista Onco.News (julho-dezembro); e054
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138187190206464

Registros relacionados